These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 31721387)

  • 1. Clinical utility of the Liver Frailty Index for predicting muscle atrophy in chronic liver disease patients with hepatocellular carcinoma.
    Hirota K; Kawaguchi T; Koya S; Nagamatsu A; Tomita M; Hashida R; Nakano D; Niizeki T; Matsuse H; Shiba N; Torimura T
    Hepatol Res; 2020 Mar; 50(3):330-341. PubMed ID: 31721387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Duke Activity Status Index and Liver Frailty Index predict mortality in ambulatory patients with advanced chronic liver disease: A prospective, observational study.
    Williams FR; Quinlan J; Freer A; Morrison B; Sitch A; Hockey F; Klas N; Towey J; Perera TPR; Rajoriya N; Lord JM; Armstrong MJ
    Aliment Pharmacol Ther; 2024 Feb; 59(4):547-557. PubMed ID: 38173029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frailty and sarcopenia in patients with cirrhosis awaiting liver transplantation: evidence from a single-centre, prospective cohort study.
    D'Arcangelo F; Zanetto A; Ferrarese A; Gambato M; Lanari J; Piano S; Germani G; Senzolo M; Russo FP; Angeli P; Cillo U; Burra P
    Updates Surg; 2024 Sep; 76(5):1807-1818. PubMed ID: 39102178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Comparison of Different Frailty Scores and Impact of Frailty on Outcome in Patients With Cirrhosis.
    Singh S; Taneja S; Tandon P; Bansal A; Gorsi U; Roy A; De A; Verma N; Premkumar M; Duseja A; Dhiman RK; Singh V
    J Clin Exp Hepatol; 2022; 12(2):398-408. PubMed ID: 35535083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparing Functional Frailty and Radiographic Sarcopenia as Predictors of Outcomes After Liver Transplant.
    Olson SL; Polineni P; Schwartz WAH; Thuluvath AJ; Duarte-Rojo A; Ladner DP
    Clin Transplant; 2024 Jul; 38(7):e15412. PubMed ID: 39049617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Applicability of laboratory deficit-based frailty index in predominantly older patients with end-stage renal disease under chronic dialysis: A pilot test of its correlation with survival and self-reported instruments.
    Chao CT; Huang JW; Chiang CK; Hung KY;
    Nephrology (Carlton); 2020 Jan; 25(1):73-81. PubMed ID: 30834584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of in-hospital exercise on liver function, physical ability, and muscle mass during treatment of hepatoma in patients with chronic liver disease.
    Koya S; Kawaguchi T; Hashida R; Goto E; Matsuse H; Saito H; Hirota K; Taira R; Matsushita Y; Imanaga M; Nagamatsu A; Shirono T; Shimose S; Iwamoto H; Niizeki T; Kuromatsu R; Miura H; Shiba N; Torimura T
    Hepatol Res; 2017 Mar; 47(3):E22-E34. PubMed ID: 27062043
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Slow walking speed overlapped with low handgrip strength in chronic liver disease patients with hepatocellular carcinoma.
    Nagamatsu A; Kawaguchi T; Hirota K; Koya S; Tomita M; Hashida R; Kida Y; Narao H; Manako Y; Tanaka D; Koga N; Nakano D; Niizeki T; Matsuse H; Torimura T; Shiba N
    Hepatol Res; 2019 Dec; 49(12):1427-1440. PubMed ID: 31273895
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Range and Reproducibility of the Liver Frailty Index.
    Wang CW; Lebsack A; Chau S; Lai JC
    Liver Transpl; 2019 Jun; 25(6):841-847. PubMed ID: 30884128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of In-Hospital Exercise on Frailty in Patients with Hepatocellular Carcinoma.
    Tsuchihashi J; Koya S; Hirota K; Koga N; Narao H; Tomita M; Kawaguchi T; Hashida R; Nakano D; Tsutsumi T; Yoshio S; Matsuse H; Sanada T; Notsumata K; Torimura T
    Cancers (Basel); 2021 Jan; 13(2):. PubMed ID: 33430438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liver Frailty Index for Prediction of Short-Term Rehospitalization in Patients with Liver Cirrhosis.
    Kaps L; Lukac L; Michel M; Kremer WM; Hilscher M; Gairing SJ; Galle PR; Schattenberg JM; Wörns MA; Nagel M; Labenz C
    Diagnostics (Basel); 2022 Apr; 12(5):. PubMed ID: 35626226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Grip strength measurement for frailty assessment in patients with vascular disease and associations with comorbidity, cardiac risk, and sarcopenia.
    Reeve TE; Ur R; Craven TE; Kaan JH; Goldman MP; Edwards MS; Hurie JB; Velazquez-Ramirez G; Corriere MA
    J Vasc Surg; 2018 May; 67(5):1512-1520. PubMed ID: 29276105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High Prevalence of Hormonal Changes and Hepatic Osteodystrophy in Frail Patients with Cirrhosis-An Observational Study.
    Singh S; Taneja S; Tandon P; De A; Verma N; Premkumar M; Duseja A; Dhiman RK; Singh V
    J Clin Exp Hepatol; 2022; 12(3):800-807. PubMed ID: 35677501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The liver frailty index is a predictor of healthcare utilization after liver transplantation in older adults.
    Wang M; Shui AM; Ruck J; King E; Rahimi R; Kappus M; Volk ML; Ganger DR; Ladner DP; Duarte-Rojo A; Huang CY; Verna EC; Lai JC
    Clin Transplant; 2024 Jan; 38(1):e15219. PubMed ID: 38064281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of C-Reactive Protein and Liver Frailty Index on Sarcopenia and Poor Outcome in Liver Transplant Patients.
    Wang A; Wang M; Li G; Zhang X; Wu M
    Clin Lab; 2024 Sep; 70(9):. PubMed ID: 39257134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frailty is associated with increased risk of cirrhosis disease progression and death.
    Wang S; Whitlock R; Xu C; Taneja S; Singh S; Abraldes JG; Burak KW; Bailey RJ; Lai JC; Tandon P
    Hepatology; 2022 Mar; 75(3):600-609. PubMed ID: 34528267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validity of maximum isometric tongue pressure as a screening test for physical frailty: Cross-sectional study of Japanese community-dwelling older adults.
    Yamanashi H; Shimizu Y; Higashi M; Koyamatsu J; Sato S; Nagayoshi M; Kadota K; Kawashiri S; Tamai M; Takamura N; Maeda T
    Geriatr Gerontol Int; 2018 Feb; 18(2):240-249. PubMed ID: 28868806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum and plasma protein biomarkers associated with frailty in patients with cirrhosis.
    Ha NB; Seetharaman S; Kent DS; Yao F; Shui AM; Huang CY; Walston J; Lai JC
    Liver Transpl; 2023 Oct; 29(10):1089-1099. PubMed ID: 36932707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of frailty in cirrhosis using bedside measures and its correlation with Child-Turcotte-Pugh, MELD & MELD-Na Scores.
    Zuberi BF; Rasheed T; Ali FS; Bader N; Sadaf R
    Pak J Med Sci; 2022; 38(5):1086-1092. PubMed ID: 35799712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A cross-sectional study on the association between frailty and muscular performances in hospitalized elder patients with coronary artery disease].
    Zhang N; Zhu WL; Liu XH; Chen W; Zhu ML; Wu W; Tian R; Han YC
    Zhonghua Nei Ke Za Zhi; 2019 Apr; 58(4):265-269. PubMed ID: 30917418
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.